spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Prince Helps Sustainable Pharma Packaging Pioneers Woolcool Celebrate 10th Anniversary


The Prince visited Woolcool’s HQ in Staffordshire to learn more about the company’s pioneering use of natural materials in insulated packaging, before unveiling a plaque marking their tenth anniversary in business. Woolcool uses 100% pure sheep’s wool – which is biodegradable, recyclable and reusable - in place of man-made insulators such as polystyrene.

During his visit on July 19, The Prince - who is Patron of The Campaign for Wool – talked with Woolcool staff and met representatives from The National Trust and British Wool, who provide the types of wool used by the company.

His Royal Highness has championed the use of wool by industry since The Campaign for Wool was launched in 2010.

During a speech at the reception, he said: “I have been enormously impressed by the remarkable degree of innovation and ingenuity which is clearly going on in this country in producing fascinating alternatives to synthetic products, artificial products and man-made things.

“For me, having started The Wool Campaign all those years ago, it is important to remind people of how valuable and sustainable wool is as a fibre and as a natural material and Woolcool has taken it further by demonstrating just how important that material is.”

Woolcool specialises in sustainable, insulated packaging for the transportation of temperature-sensitive goods for the food and pharmaceutical sectors. Last year the firm received a Queen's Award for Enterprise in the Innovation category.

Key customers and partners such as Gousto, Abel & Cole and Fortnum and Mason also attended last week’s Royal visit.

Company founder and CEO Angela Morris said: “The Prince’s visit to Woolcool was a wonderful way to mark our tenth anniversary and an event that everyone here will remember for the rest of their lives.

“His Royal Highness was very interested to hear about how we have pioneered a sustainable use of wool in packaging. He also took time to talk to everyone during his visit.”

Strategic Director Keith Spilsbury commented: “The Prince seemed very impressed with our testing facilities – where we put our packaging through vigorous temperature trials – and knew his facts about the challenges we face and the properties of wool.”

Managing director Josie Morris added: “The excitement towards The Prince’s visit has been building for a while. Our Finance Director, Jessica, oversaw so many of the arrangements to get everything just right, but was unfortunately unable to attend on the day.

“We try to create a sense of community at Woolcool, both among our team and with our partners, customers and suppliers, and we wanted today’s visit to be a reflection of that ethos, because so many people have contributed to our success over ten years.

“I would like to thank everyone who joined us on this special occasion to help celebrate our anniversary. To mark this milestone among our friends, and in the presence of His Royal Highness, was truly memorable.”
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>


White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

Industry Events

ESMO Targeted Anticancer Therapies Congress 2020

2-4 March 2020, Paris, France

A unique and international mix of experts, researchers and decision makers both from academia and industry across the globe, will convene in Paris for a three-day Congress aiming at exchanging knowledge, experience and research innovations in cancer. TAT 2020 will focus, among others, on novel strategies in immuno-oncology, personalised medicine and molecular tumour boards, preclinical studies to identify effective combination therapies, use of microbiome, tumour agnostic trials, ADC technology, oncolytics, multispecific biological constructs and targeting cytokines. Participating in TAT 2020 will offer you the possibility to take part in interdisciplinary discussions inspiring new ideas and new collaborations.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement